In malignant tumors, constitutively activated HER2 and EGFR/HER1 not surprisingly stimulate many of the same intracellular signaling proteins and pathways as wild-type receptors, such as the MAPK, PI3K/AKT/mTOR pathway, Src kinase, and STAT transcription factors (25). This evidence concerns the gene SOAT1 and cancer.